Method sharpens proteome-wide view of structural changes
Protein structure underlies function, and shifts in that structure can reveal changes in cell signaling, metabolism, stress responses and genetic variation. But tracking such structural changes across the proteome remains a challenge. Luise Nagel of the University of Cologne and colleagues in Switzerland developed a method using limited proteolysis coupled with mass spectrometry, or LiP–MS, to distinguish true structural changes from confounding factors such as protein abundance. They published their findings in Molecular & Cellular Proteomics.
LiP–MS works by probing protein structures with proteinase K, or PK, a protease whose digestion patterns shift when proteins change shape. The team validated their method using samples from budding yeast, fission yeast and human cerebrospinal fluid.
To isolate structural signals, they built a framework to remove unwanted variation (RUV) from LiP–MS data. The framework outperformed other approaches by separating structural changes from effects such as protein abundance, posttranslational modifications and alternative splicing. Beyond LiP–MS, the framework could apply to other peptide-centric structural proteomics methods, including fast photochemical oxidation of proteins and molecular painting.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles

Discoveries made possible by DNA
The discovery of DNA’s double helix revealed how genetic information is stored, copied and expressed. Revisit that breakthrough and traces how it laid the foundation for modern molecular biology, genomics and biotechnology.

Unraveling the language of histones
Philip Cole presented his research on how posttranslational modifications to histones are involved in gene expression and how these modifications could be therapeutically targeted to treat diseases like cancer.

How Alixorexton could transform narcolepsy treatment
A new investigational drug, alixorexton, targets the brain’s orexin system to restore wakefulness in people with narcolepsy type 1. Alkermes chemist Brian Raymer shares how molecular modeling turned a lab idea into a promising phase 3 therapy.

Phosphatases and pupils: A dual legacy
Yale professor Anton Bennett explores how protein tyrosine phosphatases shape disease, while building a legacy of mentorship that expands opportunity and fuels discovery in biochemistry and molecular biology.

Extracellular vesicles offer clues to cattle reproduction
Extracellular vesicles from pregnant cattle support embryo development better than laboratory models, highlighting their potential to improve reproductive efficiency in bovine embryo cultures. Read more about this recent MCP paper.

Proteomics reveals protein shifts in diabetic eye disease
Using proteomics, researchers identified protein changes in eye fluid that mark diabetic retinopathy progression and may serve as biomarkers for vision-threatening complications. Read more about this recent MCP paper.